RESOLVE MOLECULAR DIAGNOSTICS Revenue and Competitors

Headquartered in Franklin, TN, Resolve Molecular Diagnostics (Resolve MDx), is a leading molecular diagnostic solutions company. Our focus is to provide healthcare professionals with precise, timely genetic data used to guide best possible treatment plans and enhance patient wellbeing, safety, and satisfaction. RMDx currently provides pharmacogenetic and nutritional genetics testing services to physician offices, corporate wellness health systems, and self- insured companies. RMDx is advancing its lab capabilities and services to include the new TaqPath COVID-19 Kit. This is a fast, highly sensitive multiplex diagnostic solution for real-time PCR detection of RNA from the SARS-CoV-2 virus, which causes Coronavirus Disease 19 (COVID-19). Our dedicated team and instruments ensure that healthcare providers, employers, corporate wellness, and occupational medicine entities have access to the utmost accuracy, highest precision, and fastest results in genetics testing. Since its founding in 2016, Resolve Molecular Diagnostics (RMDx) has been an innovator in genetic testing for healthcare providers. Resolve MDx offers healthcare professionals and their patients a diagnostic test that provides insight into a patient’s genetic makeup, pharmacogenomics (PGT). This genetic information correlates to how a patient metabolizes various medications determining if they are likely to have an adverse effect. The data gleaned from the test helps healthcare professionals evaluate individual genotypes and develop strategies to: • Optimize drug therapies for each patient • Minimize the potential for adverse drug effects • Reduce drug-drug interactions